Pharmacy Articles

Pharmacy

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Tse KC et al. – The authors conclude that both adefovir and entecavir are effective in the treatment of lamivudine–resistant HBV in renal allograft recpients, and the reduction of HBV DNA to <105 copies/mL could be slow.

Related Articles

The Alphabet Soup of Kidney Transplantation: SCD, DCD, ECD—Fundamentals for the Practicing Nephrologist
Clinical Journal of the American Society of Nephrology, 11/16/09    Relevance Score: 70%

The Evolution of Kidney Function After Lung Transplantation: A Retrospective Cohort Study
Transplantation Proceedings, 11/11/09    Relevance Score: 70%

ABO-Incompatible Kidney Transplantation
Transplantation, 10/29/09    Relevance Score: 70%

Ethical Issues and Living Unrelated Donor Kidney Transplantation
Iranian Journal of Kidney Diseases, 10/13/09    Relevance Score: 69%

The Science of Stewardship: Due Diligence for Kidney Donors and Kidney Function in Living Kidney Donation—Evaluation, Determinants, and Implications for Outcomes
Clinical Journal of the American Society of Nephrology, 10/08/09    Relevance Score: 69%


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address